Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 13 open reading frame 42 (C13orf42) is a gene that encodes a predicted protein in humans, with some isoforms also producing long non-coding RNAs (LINC00371, LINC00372). The protein is predicted to localize to the nucleus, cytosol, mitochondria, and, to a much lesser extent, the endoplasmic reticulum. Expression is low across most human tissues. There are multiple transcript variants, but only some encode proteins. The protein is highly serine-, lysine-, and arginine-rich, with post-translational modification sites for phosphorylation and glycosylation. The gene has no known conserved domains and remains uncharacterized at the functional level, and its molecular or cellular role is unknown. There is very limited evidence linking C13orf42 to clinical significance: a chromosomal fusion of C13orf42 with ATM has been observed in a patient with chronic lymphocytic leukemia (possibly relevant for cancer biology), and one SNP in the gene is associated with facial shape variation. No drugs, validated disease mechanisms, or biomarker roles are known.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 13 open reading frame 42 (C13orf42).